Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 2, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 21, 2026Reported sale · Form 4Earl Martin Douglas, SVP, General Counsel · $63.0KOpen the filing ↗
- Aug 21, 2026Notice of sale · Form 144Douglas Earl Martin · Officer · $63.0KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record55520 flagged findings
Reported transactions (Form 4)80since Jun 5, 2024 · and 17 other holdings
Corporate events (8-K)27since Oct 29, 2018
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-06-22capital return (buybacks/dividends)recentOpen filing ↗“…time to time, we may offer and sell up to an aggregate amount of $500,000,000 of any combination of shares of our common stock,…”
+1 more passage from the same document
- “…dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate; • our right, if…”
- 2026-05-13share offering or dilution eventrecentOpen filing ↗“…at greater scale, and to more patients. Public Offerings In November 2019, the Company entered into a sales agreement with TD…”
+1 more passage from the same document
- “…value) in the equity ownership of certain stockholders over a rolling three-year period), the corporation’s ability to use its…”
- 2026-05-13Department of Justice inquiryrecentOpen filing ↗“…particularly to the United States, are subject to increased scrutiny from regulators, individual litigants, and activist…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 555)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 30, 26SCHEDULE 13D/A ↗Stake with intent to influence · amendment
- Sep 2, 268-K ↗Current report · A senior executive left or was appointed
- Aug 25, 26Form 4 ↗Insider transaction
- Aug 21, 26Form 144 ↗Notice of proposed sale
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Frazier Life Sciences Public Fund, L.P. · 5.6% · event on Jun 30, 26 · amendment
- Aug 12, 26S-3 ↗Securities offering
- Aug 12, 2610-Q ↗Quarterly report
- Aug 12, 268-K ↗Current report · Results
- Aug 7, 26SCHEDULE 13G/A ↗Passive stake · Arie Belldegrun, M.D. · 3.9% · event on Jun 30, 26 · amendment
- Aug 7, 26SCHEDULE 13G ↗Passive stake · STATE STREET CORPORATION · 5.5% · event on Jun 30, 26
Insider transaction · 8 Form 4 filingsshow all 8hide
- Jun 22, 268-K ↗Current report · Shareholder vote results · Other events
- Jun 22, 26424B5 ↗Securities offering
- May 28, 26DEFA14A ↗Shareholder meeting and votes
- May 28, 268-K ↗Current report · A senior executive left or was appointed
- May 21, 26DEFA14A ↗Shareholder meeting and votes
- May 15, 26SCHEDULE 13G/A ↗Passive stake · Kenneth Griffin · 2.8% · event on Mar 31, 26 · amendment
- May 15, 26SCHEDULE 13G/A ↗Passive stake · amendment
555 filings on record, the oldest from Sep 11, 18.
Listing the 25 most recent filings of the 555 on record.
21114
- Sep 2, 26A senior executive left or was appointed8-K 5.02 ↗
- May 28, 26A senior executive left or was appointed8-K 5.02 ↗
- May 13, 26Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Feb 25, 25Entered a material agreement8-K 1.01 ↗
- Jan 29, 25A senior executive left or was appointed8-K 5.02 ↗
- Jun 10, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 31, 24Entered a material agreement8-K 1.01 ↗
- Feb 16, 24Past accounts declared unreliable and being restated8-K 4.02 ↗
- Jan 31, 24Entered a material agreement8-K 1.01 ↗
- Jan 5, 24Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
6 senior executive changes2022 – 2023show all 6hide
- Oct 17, 23A senior executive left or was appointed8-K/A 5.02 ↗
- Oct 16, 23A senior executive left or was appointed8-K 5.02 ↗
- Jun 14, 23A senior executive left or was appointed8-K 5.02 ↗
- Apr 20, 23A senior executive left or was appointed8-K 5.02 ↗
- Jan 3, 23A senior executive left or was appointed8-K 5.02 ↗
- Jul 12, 22A senior executive left or was appointed8-K 5.02 ↗
- Dec 15, 21Entered a material agreement+1 more in the same filing8-K 1.01 ↗
8 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Pfizer Inc.9.0%Nov 6, 25SCHEDULE 13D/A ↗
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Frazier Life Sciences Public Fund, L.P.5.6%Jun 30, 26SCHEDULE 13G/A ↗14 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- STATE STREET CORPORATION5.5%Jun 30, 26SCHEDULE 13G ↗
- David D. Chang, M.D., Ph.D.4.9%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- Arie Belldegrun, M.D.3.9%Jun 30, 26SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
- Kenneth Griffin2.8%Mar 31, 26SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Aug 21, Douglas Earl Martin filed notice of intent to sell up to $63K.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $63K on Aug 21, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
- Aug 21, 26Sell$63KEarl Martin DouglasSVP, General Counsel↗
- Apr 21, 26Sell$22KAnnie YoshiyamaSVP, Finance↗
- Mar 31, 26Sell$7KBenjamin Machinas BeneskiSVP, Chief Technical Officer↗
- Mar 16, 26Sell$118KDavid D ChangPresident and CEO↗
- Mar 16, 26Sell$12KBenjamin Machinas BeneskiSVP, Chief Technical Officer↗
- Mar 2, 26Sell$19KBenjamin Machinas BeneskiSVP, Chief Technical Officer↗
- Feb 2, 26Sell$40KEarl Martin DouglasSVP, General Counsel↗
- Feb 2, 26Sell$63KZachary RobertsEVP of R&D↗
- Feb 2, 26Sell$7KAnnie YoshiyamaSVP, Finance↗
- Feb 2, 26Sell$42KGeoffrey M. ParkerCHIEF FINANCIAL OFFICER↗
- Feb 2, 26Sell$171KDavid D ChangPresident and CEO↗
- Feb 2, 26Sell$13KBenjamin Machinas BeneskiSVP, Chief Technical Officer↗
There are 17 more transactions in this stretch.
Stock compensation, tax and giftsshow the 11 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Jun 18, 26Compensationamount n/aJoshua A Kazam↗
- Dec 18, 25Compensationamount n/aJoshua A Kazam↗
- Mar 1, 25Compensationamount n/aBenjamin Machinas BeneskiSVP, Chief Technical Officer↗
- Jan 24, 25Compensationamount n/aDavid D ChangPresident and CEO↗
- Jan 24, 25Compensationamount n/aArie Belldegrun↗
- Jan 24, 25Compensationamount n/aZachary RobertsEVP of R&D↗
- Jan 24, 25Compensationamount n/aAnnie YoshiyamaSVP, Finance↗
- Jan 24, 25Compensationamount n/aGeoffrey M. ParkerCHIEF FINANCIAL OFFICER↗
- Jan 24, 25Compensationamount n/aEarl Martin DouglasSVP, General Counsel↗
- Oct 21, 24Tax$103KGeoffrey M. ParkerCHIEF FINANCIAL OFFICER↗
- Aug 21, 24Tax$79KEarl Martin DouglasSVP, General Counsel↗
The full record holds 83 transactions and goes back to Jan 17, 23.
Its sector and its market
Allogene Therapeutics Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Allogene Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Allogene Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 555 documents on file, from Sep 11, 2018 to Sep 30, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.